Heating the body to fight pancreatic cancer: a new trial tests Whole-Body hyperthermia
Disease control
Not yet recruiting
This trial investigates whether raising the body's core temperature to 41.5°C for 4 hours, called whole-body hyperthermia, can improve outcomes when added to standard chemotherapy for people with metastatic pancreatic cancer that has progressed after initial treatment. The study …
Phase: PHASE2, PHASE3 • Sponsor: ElmediX • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC